Inhibitory effects of grape skin extract and resveratrol on fatty acid synthase

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Liang, Yan ^a,b   Tian, Weixi ^a   Ma, Xiaofeng ^a  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b CAPITAL UNIVERSITY OF PHYSICAL EDUCATION AND SPORTS   (China)

Author keywords

3 T3 L1 Preadipocytes; Fatty acid synthase; Grape skin extract; Inhibitor; Obesity; Resveratrol; ketoacyl reductase

Indexed keywords

3 OXOACYL REDUCTASE; ACETIC ACID ETHYL ESTER; ACETYL COENZYME A; FATTY ACID SYNTHASE; FATTY ACID SYNTHASE INHIBITOR; GRAPE SKIN EXTRACT; LIPID; MALONYL COENZYME A; OXIDOREDUCTASE; PLANT EXTRACT; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHEMICAL REACTION; CHICKEN; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME KINETICS; FATTY ACID SYNTHESIS; IC 50; LIPID STORAGE; LIVER; NONHUMAN; PROADIPOCYTE;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL SURVIVAL; ENZYME INHIBITORS; FATTY ACID SYNTHASES; LIPIDS; LIPOGENESIS; MICE; OXIDOREDUCTASES; PLANT EXTRACTS; STILBENES; VITIS;

EID: 84890257356     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-361     Document Type: Article

References (47)

1. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity related glomerulopathy: an emerging epidemic. Kidney Int 2001, 59(4):1498-1509.
2. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004, 140(3):167-174.
3. Pan SY, Desmeules M, Morrison H, Wen SW. Obesity, high energy intake, lack of physical activity and the risk of kidney cancer. Cancer Epidemiol Biomarkers Prev 2006, 15:2453-2460.
4. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC. International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645. International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity.
5. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010, 56:1113-1132.
6. Onat A. Metabolic syndrome: nature, therapeutic solutions and options. Expert Opin Pharmacother 2011, 12:1887-1900.
7. Jeong YS, Hong JH, Cho KH, Jung HK. Grape skin extract reduces adipogenesis- and lipogenesis-related gene expression in 3 T3-L1 adipocytes through the peroxisome proliferator-activated receptor-γ signaling pathway. Nutr Res 2012, 32(7):514-521.
8. Farmer SR, Auwerx J. Adipose tissue: new therapeutic targets from molecular and genetic studies-IASO stock conference 2003 report. Obes Rev 2004, 5:189-196.
9. Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 2003, 14(3):281-287.
10. Unger RH. Lipotoxic diseases. Annu Rev Med 2002, 53:319-336.
11. Unger RH, Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 2001, 15(2):312-321.
12. Weinberg JM. Lipotoxicity. Kidney Int 2006, 70(9):1560-1566.
13. Vazquez-Vela ME, Torres N, Tovar AR. White adipose tissue as endocrine organ and its role in obesity. Arch Med Res 2008, 39:715-728.
14. Loftus TM, Jaworsky DE, Frehywot GL, Townsend CA, Ronnett GV, Lane MD, Kuhajda FP. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 2000, 288:2379-2381.
15. Wakil SJ. Fatty acid synthase, a proficient multifunctional enzyme. Biochem 1989, 28:4523-4530.
16. Smith S. The animal fatty acid synthase: one gene, one polypeptide, seven enzymes. FASEB J 1994, 8:1248-1259.
17. Guichard C, Dugail I, Leliepvre X, Lavau M. Genetic-regulation of fatty-acid synthetase expression in adipose tissue over transcription of the gene in genetically-obese rats. J Lipid Res 1992, 33:679-687.
18. Rolland V, Dugail I, Leliepvre X, Lavau M. Evidence of increased glyceraldehyde-3-phosphate dehydrogenase and fatty-acid synthetase promoter activities in transiently transfected adipocytes from geneticallyobese rats. J Biol Chem 1995, 270:1102-1106.
19. Berndt J, Kovacs P, Ruschke K, Kloting N, Fasshauer M, Schon MR, Korner A, Stumvoll M, Bluher M. Fatty acid synthase gene expression in human adipose tissue: association with obesity and type 2 diabetes. Diabetologia 2007, 50:1472-1480.
20. Serrano J, Puupponen-Pimiä R, Dauer A, Aura AM, Saura-Calixto F. Tannins: current knowledge of food sources, intake, bioavailability and biological effects. Mol Nutr Food Res 2009, 53(Suppl):310-329.
21. Bladé C, Arola L, Salvadó MJ. Hypolipidemic effects of proanthocyanidins and their underlying biochemical and molecular mechanisms. Mol Nutr Food Res 2010, 54(1):37-59.
22. Nandakumar V, Singh T, Katiyar SK. Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett 2008, 269(2):378-387.
23. Ramirez-Tortosa C, Andersen OM, Gardner PT, Morrice PC, Wood SG, Duthie SJ, Collins AR, Duthie GG. Anthocyanin-rich extract decreases indices of lipid peroxidation and DNA damage in vitamin edepleted rats. Free Radic Biol Med 2001, 31:1033-1037.
24. Lee SJ, Choi SK, Seo JS. Grape skin improves antioxidant capacity in rats fed a high fat diet. Nutr Res Pract 2009, 3:279-285.
25. Jeong YS, Jung HK, Cho KH, Hong JH. Anti-obesity effect of grape skin extract in 3 T3-L1 adipocytes. Food Sci Biotechnol 2011, 20:635-642.
26. Stervbo U, Vang O, Bonnesen C. A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine. Food Chem 2007, 101(2):449-457.
27. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, De Cabo R, Sinclair DA. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
28. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserve P, Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
29. Timmers S, Konings E, Bilet L, Houtkooper RH, Van de Weijer T, Goossens GH, Hoeks J, Van der Krieken S, Ryu D, Kersten S, Moonen-Kornips E, Hesselink MKC, Kunz I, Schrauwen-Hinderling VB, Blaak EE, Auwerx J, Schrauwen P. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 2011, 14:612-622.
30. Jayakumar A, Tai MH, Huang WY, Al-Feel W, Hsu M, Abu-Elheiga L, Chirala SS, Wakil SJ. Human fatty acid synthase: properties and molecular cloning. Proc Natl Acad Sci USA 1995, 92:8695-8699.
31. Tian WX, Hsu RY, Wang YS. Studies on the reactivity of the essential sulfhydryl groups as a conformational probe for the fatty acid synthetase of chicken liver: inactivation by 5, 5′-dithiobis-(2-nitrobenzoic acid) and intersubunit cross-linking of the inactivated enzyme. J Biol Chem 1985, 260:11375-11387.
32. Sun YH, Cheng Q, Tian WX, Wu XD. A substitutive substrate for measurements of beta-ketoacyl reductases in two fatty acid synthase systems. J Biochem Biophys Methods 2008, 70(6):850-856.
33. Wang X, Tian WX. Green tea epigallocatechin gallate: a natural inhibitor of fatty-acid synthase. Biochem Biophys Res Commun 2001, 288:1200-1206.
34. Wang X, Song KH, Guo QX, Tian WX. The galloyl moiety of green tea catechins is critical structural feature to inhibit fatty-acid synthase. Biochem Pharmacol 2003, 66:2039-2047.
35. Kuhajda FP, Pizer ES, Li JN, Mani NS, Frehywot GL, Townsend CA. Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc Natl Acad Sci USA 2000, 97(7):3450-3454.
36. Zhang R, Xiao W, Wang X, Wu X, Tian W. Novel inhibitors of fatty-acid synthase from green tea (Camellia sinensis Xihu Longjing) with high activity and a new reacting site. Biotechnol Appl Biochem 2006, 43:1-7.
37. Li BH, Ma XF, Wang Y, Tian WX. Structure-activity relationship of polyphenols that inhibit fatty acid synthase. J Biochem (Tokyo) 2005, 138(6):679-685.
38. Watson WH, Cai J, Jones DP. Diet and apoptosis. Annu Rev Nutr 2000, 20:485-505.
39. Matito C, Mastorakou F, Centelles JJ, Torres JL, Cascante M. Antiproliferative effect of antioxidant polyphenols from grape in murine Hepa-1c1c7. Eur J Nutr 2003, 42:43-49.
40. Formica JV, Regelson W. Review of the biology of Quercetin and related bioflavonoids. Food Chem Toxicol 1995, 33:1061-1080.
41. Plaumann B, Fritsche M, Rimpler H, Brandner G, Hess RD. Flavonoids activate wild-type p53. Oncogene 1996, 13:1605-1614.
42. Caltagirone S, Rossi C, Poggi A, Ranelletti FO, Natali PG, Brunetti M, Aiello FB, Piantelli M. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer 2000, 87:595-600.
43. Schmid B, Rippmann JF, Tadayyon M, Hamilton BS. Inhibition of fatty acid synthase prevents preadipocyte differentiation. Biochem Biophys Res Commun 2005, 328:1073-1082.
44. Clarde WL, Armstrong MK, Jump DB. Nutritional control of rat liver fatty acid synthase and S14 mRNA abundance. J Nutr 1990, 120:218-224.
45. Mobbs CV, Makimura H. Block the FAS, lose the fat. Nutr Med 2002, 8:335-336.
46. Moon HS, Chung CS, Lee HG, Kim TG, Choi YJ, Cho CS. Inhibitory effect of (-)-epigallocatechin-3-gallate on lipid accumulation of 3 T3-L1 cells. Obesity 2007, 15(11):2571-2582.
47. Thupari JN, Pinn ML, Kuhajda FP. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity. Biochem Biophys Res Commun 2001, 285(2):217-223.